Wang Xinyi, Lei Jianyong, Su Anping, Wei Tao, Li Zhihui, Zhang Kun
Division of Thyroid Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Endocrine. 2025 Jun 5. doi: 10.1007/s12020-025-04281-0.
Primary Thyroid Sarcoma (PTS) accounts for 1-2% of thyroid malignancies with limited survival data available. And it might be misidentified as the spindle cell subtype of anaplastic thyroid carcinoma (ATC) due to overlapping pathological features, which poses a significant diagnostic challenge.
A total of 42 PTS patients from 2000 to 2018 were screened from the Surveillance, Epidemiology, and End Results (SEER) database. Kaplan-Meier survival curve, Cox proportional hazard regression were applied.
Most patients with PTS are middle-aged to old, predominantly white, and slightly more female. The 5-year overall survival (OS) and 5-year disease specific survival (DSS) were 28.3% and 60.5%, respectively. Older age (>55 vs <=40, HR = 6.45, 95% CI 2.16-19.24, P < 0.001), undifferentiated pathological grade (vs moderately differentiated, HR = 17.02, 95% CI 1.74-166.89, P = 0.015), higher SEER stage (e.g., distant vs localized, HR = 7.76, 95% CI 2.12-8.84, P = 0.002), distant metastasis (M1 vs M0, HR = 2.93, 95% CI 1.09-7.91, P = 0.034) and no surgery performed (lobectomy vs no surgery, HR = 0.11, 95% CI 0.03-0.42, P = 0.001; total thyroidectomy vs no surgery, HR = 0.05, 95% CI 0.01-0.20, P < 0.001) were identified as independent prognostic factors, in which, surgery is the only factor that improves survival outcomes of PTS patients.
The current study outlined the features of PTS patients in demographic and clinical characteristics, survival outcomes, prognostic factors, general layout of cause of deaths and the desicive role of surgery in improving its survival benefits.
原发性甲状腺肉瘤(PTS)占甲状腺恶性肿瘤的1%-2%,现有生存数据有限。由于病理特征重叠,它可能被误诊为间变性甲状腺癌(ATC)的梭形细胞亚型,这带来了重大的诊断挑战。
从监测、流行病学和最终结果(SEER)数据库中筛选出2000年至2018年共42例PTS患者。应用Kaplan-Meier生存曲线和Cox比例风险回归分析。
大多数PTS患者为中老年,以白人为主,女性略多。5年总生存率(OS)和5年疾病特异性生存率(DSS)分别为28.3%和60.5%。年龄较大(>55岁对比≤40岁,HR = 6.45,95%CI 2.16-19.24,P < 0.001)、病理分级未分化(对比中度分化,HR = 17.02,95%CI 1.74-166.89,P = 0.015)、SEER分期较高(如远处转移对比局限性转移,HR = 7.76,95%CI 2.12-8.84,P = 0.002)、远处转移(M1对比M0,HR = 2.93,95%CI 1.09-7.91,P = 0.034)以及未进行手术(叶切除术对比未手术,HR = 0.11,95%CI 0.03-0.42,P = 0.001;全甲状腺切除术对比未手术,HR = 0.05,95%CI 0.01-0.20,P < 0.001)被确定为独立的预后因素,其中,手术是改善PTS患者生存结局的唯一因素。
本研究概述了PTS患者在人口统计学和临床特征、生存结局、预后因素、死亡原因总体情况以及手术在改善其生存获益方面的决定性作用。